Hong Je Park

Title: Innovations of Hong Je Park in Monoclonal Antibody Development

Introduction

Hong Je Park is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work focuses on enhancing detection methods for foodborne pathogens, which is crucial for public health and safety.

Latest Patents

Hong Je Park holds a patent for a monoclonal antibody that selectively recognizes Listeria monocytogenes. This invention includes a hybridoma producing the antibody, a test kit comprising the antibody, and a detection method for Listeria monocytogenes using the antibody. The monoclonal antibody binds specifically to the p60 protein of Listeria, allowing for rapid determination of food contamination with this pathogenic bacterium.

Career Highlights

Park's career is marked by his innovative approach to addressing food safety issues. His patent demonstrates his commitment to developing effective solutions that can be utilized in various food industry applications. His work has the potential to significantly reduce the risks associated with foodborne illnesses.

Collaborations

Hong Je Park has collaborated with notable colleagues, including Byung Soo Youn and Young Soo Yang. These partnerships have likely contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Hong Je Park's contributions to the field of monoclonal antibodies represent a significant advancement in food safety technology. His innovative work continues to impact public health positively.